HIV-Positive Women: Ablation Plus Chemotherapy for HPV
Part of Cancer, Immune system & allergy, Infections, Women’s health & pregnancy clinical trials.
This study tests whether a chemotherapy cream (5-fluorouracil) applied after heat treatment can better prevent cervical and anal precancers in women with HIV. The goal is to improve outcomes for women in Kenya who test positive for HPV, a virus that can cause cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 25 or older
- You have HIV and have been taking HIV medications consistently for at least 2 months
- You tested positive for HPV (human papillomavirus)
- You are able to stay in the study location for the full 48 weeks (about 1 year)
- You can read and speak English, Swahili, or Dholuo, and can give informed consent
- If you can become pregnant, you agree to use two forms of birth control during treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding HPV vaccination to the cervical cancer screening plan—while you get care at HIV (ARV) clinics—improves prevention of cervical problems. It focuses on women with HIV aged 25–35 to help reduce HPV-related cervical disease over time.
This study compares two treatments (Thermal Ablation and LEEP) to lower the risk of cervical cancer in women living with HIV. It aims to find which option works better and is safer for this group.
This trial compares two ways to help women with HIV get screened for cervical cancer: a clinic-based approach versus a combined clinic and community outreach program. You may be able to provide samples yourself at a clinic or at home to test for HPV, the virus that can cause cervical cancer.
This study looks at HPV infection and the natural balance of bacteria in the vagina in women with HIV. It aims to understand how these factors affect health and may guide future prevention or treatment.
This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.
This study tests two different approaches to treating early cervical changes in women living with HIV who tested positive for HPV (a virus that can cause cervical cancer). The goal is to see which approach works better and is easier to use in South Africa.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.